Jakub Radocha
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
-
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
Papers in
- Hematology 36
- Multiple Myeloma Research and Treatments 34
- Oncology 25
- Peptidase Inhibition and Analysis 9
- Cancer Treatment and Pharmacology 8
- Co-authors
- Katja Weisel (1 shared paper)Niels W.C.J. van de Donk (1 shared paper)Vladimír Maisnar (28 shared papers)Roman Hájek (30 shared papers)Miroslav Červinka (3 shared papers)Emil Rudolf (3 shared papers)Luděk Pour (19 shared papers)Radovan Slezák (4 shared papers)
In The Last Decade
Jakub Radocha
52 papers receiving 296 citations
Peers
Comparison fields: 5 of 61
- Hematology 156
- Oncology 100
- Genetics 30
- Nutrition and Dietetics 26
- Molecular Biology 85
Countries citing papers authored by Jakub Radocha
This map shows the geographic impact of Jakub Radocha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jakub Radocha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jakub Radocha more than expected).
Fields of papers citing papers by Jakub Radocha
This network shows the impact of papers produced by Jakub Radocha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jakub Radocha. The network helps show where Jakub Radocha may publish in the future.
Co-authors
The 25 scholars most cited alongside Jakub Radocha, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 33 | |
| 2 | 2003 | 19 | |
| 3 | Isotype class switching after transplantation in multiple myeloma. | 2007 | 17 |
| 4 | 2007 | 14 | |
| 5 | 2021 | 12 | |
| 6 | 2015 | 11 | |
| 7 | 2011 | 11 | |
| 8 | Combined effect of sodium selenite and campthotecin on cervical carcinoma cells. | 2004 | 11 |
| 9 | 2015 | 10 | |
| 10 | 2017 | 10 | |
| 11 | 2019 | 10 | |
| 12 | 2020 | 9 | |
| 13 | 2020 | 8 | |
| 14 | 2011 | 8 | |
| 15 | 2023 | 7 | |
| 16 | 2019 | 7 | |
| 17 | 2021 | 7 | |
| 18 | 2016 | 7 | |
| 19 | 2023 | 6 | |
| 20 | 2007 | 6 |
About Jakub Radocha
Jakub Radocha is a scholar working on Hematology, Oncology, Molecular Biology, Epidemiology and Genetics, having authored 62 papers that have together received 305 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (34 papers), Protein Degradation and Inhibitors (10 papers), Peptidase Inhibition and Analysis (9 papers), Cancer Treatment and Pharmacology (8 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Phytochemical compounds biological activities (3 papers). The work is most often cited by research in Hematology (156 citations), Oncology (100 citations), Genetics (30 citations), Nutrition and Dietetics (26 citations) and Molecular Biology (85 citations). Jakub Radocha has collaborated with scholars based in Czechia, Germany and Belgium. Frequent co-authors include Katja Weisel, Niels W.C.J. van de Donk, Vladimír Maisnar, Roman Hájek, Miroslav Červinka, Emil Rudolf, Luděk Pour, Radovan Slezák, Ivan Špıčka and Jan Peychl. Their work appears in journals such as Blood, British Journal of Haematology, Annals of Hematology, Cancers and HemaSphere.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.